We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-0.68%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$604M
AUM Growth
-$213M
Cap. Flow
-$186M
Cap. Flow %
-30.79%
Top 10 Hldgs %
13.62%
Holding
1,036
New
389
Increased
70
Reduced
105
Closed
470

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$15.4M
2
AMGN icon
Amgen
AMGN
+$11.2M
3
CRM icon
Salesforce
CRM
+$9.62M
4
DHR icon
Danaher
DHR
+$9.18M
5
UNP icon
Union Pacific
UNP
+$8.98M

Sector Composition

Rank Sector Weight
1 Technology 25.33%
2 Consumer Discretionary 16.35%
3 Healthcare 12.02%
4 Industrials 10.05%
5 Consumer Staples 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOFI icon
276
SoFi Technologies
SOFI
$21.1B
$549K 0.09%
+47,202
New +$680K
TMO icon
277
Thermo Fisher Scientific
TMO
$214B
$547K 0.09%
+1,100
New +$596K
PEGA icon
278
Pegasystems
PEGA
$4.94B
$542K 0.09%
+15,594
New +$690K
GDYN icon
279
Grid Dynamics Holdings
GDYN
$590M
$534K 0.09%
+34,100
New +$683K
DXC icon
280
DXC Technology
DXC
$1.82B
$533K 0.09%
+31,266
New +$607K
MRCY icon
281
Mercury Systems
MRCY
$5.76B
$530K 0.09%
+12,298
New +$539K
ACIW icon
282
ACI Worldwide
ACIW
$5.86B
$525K 0.09%
+9,600
New +$509K
VIAV icon
283
Viavi Solutions
VIAV
$8.65B
$524K 0.09%
+46,800
New +$521K
DT icon
284
Dynatrace
DT
$12.8B
$521K 0.09%
+11,046
New +$604K
HGV icon
285
Hilton Grand Vacations
HGV
$3.64B
$521K 0.09%
13,916
+1,916
+16% +$76.4K
URI icon
286
United Rentals
URI
$66.5B
$518K 0.09%
826
-1,256
-60% -$863K
ROIV icon
287
Roivant Sciences
ROIV
$24.8B
$515K 0.09%
+51,000
New +$552K
EVR icon
288
Evercore
EVR
$12.1B
$512K 0.08%
+2,563
New +$639K
GRPN icon
289
Groupon
GRPN
$1.06B
$511K 0.08%
+27,200
New +$344K
ACGL icon
290
Arch Capital
ACGL
$34.5B
$510K 0.08%
+5,300
New +$489K
MCD icon
291
McDonald's
MCD
$191B
$508K 0.08%
+1,625
New +$486K
GIII icon
292
G-III Apparel Group
GIII
$1.55B
$508K 0.08%
+18,556
New +$538K
CPRX
293
DELISTED
Catalyst Pharmaceutical
CPRX
$502K 0.08%
+20,700
New +$466K
RARE icon
294
Ultragenyx Pharmaceutical
RARE
$2.56B
$499K 0.08%
13,783
+5,515
+67% +$229K
TOL icon
295
Toll Brothers
TOL
$14B
$496K 0.08%
+4,700
New +$564K
BSX icon
296
Boston Scientific
BSX
$68.4B
$494K 0.08%
4,900
-8,200
-63% -$826K
MDY icon
297
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$493K 0.08%
+924
New +$525K
INFY icon
298
Infosys
INFY
$48.4B
$487K 0.08%
+26,700
New +$554K
CRGY icon
299
Crescent Energy
CRGY
$3.69B
$487K 0.08%
43,300
+23,002
+113% +$317K
TTMI icon
300
TTM Technologies
TTMI
$12B
$487K 0.08%
+23,722
New +$573K

Similar funds

Bayesian Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Bayesian Capital Management held 1,036 positions worth $604M, down 26% from $817M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Bayesian Capital Management withdrew a net $186M in Q1 2025, closing 470 positions and reducing 105 holdings. Its most notable exit was Amgen, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Advanced Micro Devices worth $9.96M.

  • Bayesian Capital Management's largest Q1 2025 buy was Advanced Micro Devices: 96,900 shares worth $9.96M.
  • Bayesian Capital Management added most to Cisco in Q1 2025, an estimated $12.4M increase.
  • Bayesian Capital Management's biggest Q1 2025 reduction was Nike, cutting an estimated $15.4M.
  • Bayesian Capital Management fully exited Amgen in Q1 2025, selling an estimated $11.2M.
  • Bayesian Capital Management's ten largest holdings make up 14% of its $604M portfolio in Q1 2025.
  • Bayesian Capital Management opened 389 new positions and closed 470 in Q1 2025.
  • Bayesian Capital Management's portfolio value fell 26% quarter-over-quarter to $604M.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.